Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
NINA, BHARDWAJ,	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI United States	Immune determinants modulating cancer development in Lynch Syndrome	1UG3CA290517-01
Nolan, Michael Warren	North Carolina State University Raleigh United States	Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer	5R37CA248797-05		Asad Umar, D.V.M., Ph.D.
Nyamathi, Adeline M	University Of California-Irvine United States	Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India	3R01CA285063-03S2		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-04		Guillermo Marquez, Ph.D.
Ochoa, Augusto C.	Lsu Health Sciences Center United States	Gulf South Clinical Trials Network (Gulf South NCORP)	3UG1CA189854-11S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Olopade, Olufunmilayo F.	University Of Chicago United States	The Funding Mechanism of the Pilot Trial	5R01CA276652-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.	University Of Minnesota United States	Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	5R01CA254270-04	PAR-21-035 (R01 Clinical Trial Required)	Malgorzata Wojtowicz, M.D.
Onitilo, Adedayo A	Marshfield Clinic Research Foundation United States	Wisconsin NCI Community Oncology Research Program (WiNCORP)	3UG1CA189956-11S1		Vanessa A. White, M.P.H.
Osarogiagbon, Raymond U	Baptist Memorial Hospital - Tipton United States	Baptist Memorial Health Care/Mid South NCORP Consortium	3UG1CA189873-11S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02		Guillermo Marquez, Ph.D.